Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes

Cell Rep. 2016 Jun 21;15(12):2616-24. doi: 10.1016/j.celrep.2016.05.042. Epub 2016 Jun 9.

Abstract

Glioblastoma multiforme is a heterogeneous and infiltrative cancer with dismal prognosis. Studying the migratory behavior of tumor-derived cell populations can be informative, but it places a high premium on the precision of in vitro methods and the relevance of in vivo conditions. In particular, the analysis of 2D cell migration may not reflect invasion into 3D extracellular matrices in vivo. Here, we describe a method that allows time-resolved studies of primary cell migration with single-cell resolution on a fibrillar surface that closely mimics in vivo 3D migration. We used this platform to screen 14 patient-derived glioblastoma samples. We observed that the migratory phenotype of a subset of cells in response to platelet-derived growth factor was highly predictive of tumor location and recurrence in the clinic. Therefore, migratory phenotypic classifiers analyzed at the single-cell level in a patient-specific way can provide high diagnostic and prognostic value for invasive cancers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Brain Neoplasms / pathology*
  • Cell Movement*
  • Glioblastoma / pathology
  • Humans
  • Mice
  • Nanoparticles / chemistry
  • Neoplasm Invasiveness
  • Phenotype
  • Platelet-Derived Growth Factor / pharmacology
  • Treatment Outcome
  • Tumor Microenvironment

Substances

  • Platelet-Derived Growth Factor